Variant report

Variant	nsv882223
Chromosome Location	chr5:79330559-79357117
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:106)
CpG islands
(count:610)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:106 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr5:79342589-79342693	K562	blood:	n/a	n/a
2	ATF1	chr5:79337452-79337476	K562	blood:	n/a	n/a
3	BACH1	chr5:79330830-79331030	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr5:79350530-79350841	GM12878	blood:	n/a	chr5:79350717-79350728
5	BRCA1	chr5:79335424-79335435	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr5:79356589-79356656	HepG2	liver:	n/a	chr5:79356598-79356609
7	CTCF	chr5:79342520-79342670	BE2_C	brain:	n/a	n/a
8	CTCF	chr5:79339787-79339899	Lung_OC	lung:	n/a	n/a
9	CTCF	chr5:79342538-79342615	Hela-S3	cervix:	n/a	n/a
10	CTCF	chr5:79342560-79342710	HepG2	liver:	n/a	n/a
11	CTCF	chr5:79342523-79342739	GM12878	blood:	n/a	n/a
12	CTCF	chr5:79342520-79342670	AG09309	skin:	n/a	n/a
13	CTCF	chr5:79342460-79342679	HepG2	liver:	n/a	n/a
14	CTCF	chr5:79339480-79339630	GM12878	blood:	n/a	n/a
15	CTCF	chr5:79339520-79339670	Caco-2	colon:	n/a	chr5:79339640-79339661
16	CTCF	chr5:79354060-79354210	HRE	kidney:	n/a	n/a
17	CTCF	chr5:79342513-79342650	K562	blood:	n/a	n/a
18	CTCF	chr5:79356160-79356310	HepG2	liver:	n/a	chr5:79356161-79356174
19	CTCF	chr5:79342426-79342728	K562	blood:	n/a	n/a
20	CUX1	chr5:79333620-79333684	GM12878	blood:	n/a	n/a
21	EBF1	chr5:79351519-79351997	GM12878	blood:	n/a	chr5:79351694-79351705 chr5:79351780-79351791
22	EP300	chr5:79351315-79352243	ECC-1	luminal epithelium:	n/a	chr5:79351934-79351943
23	ESR1	chr5:79351666-79352101	ECC-1	luminal epithelium:	n/a	n/a
24	FOS	chr5:79350516-79350883	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr5:79350548-79350867	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr5:79350546-79350868	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr5:79351627-79351877	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr5:79350511-79350910	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr5:79351751-79351915	MCF10A-Er-Src	breast:	n/a	n/a
30	FOXA1	chr5:79337241-79337478	T-47D	breast:	n/a	n/a
31	FOXP2	chr5:79356631-79356988	SK-N-MC	brain:	n/a	n/a
32	GABPA	chr5:79331120-79331398	H1-hESC	embryonic stem cell:	n/a	n/a
33	GTF2F1	chr5:79330455-79330623	H1-hESC	embryonic stem cell:	n/a	n/a
34	HMGN3	chr5:79331220-79331420	K562	blood:	n/a	n/a
35	IKZF1	chr5:79333373-79333672	GM12878	blood:	n/a	n/a
36	JUN	chr5:79330860-79330920	H1-hESC	embryonic stem cell:	n/a	n/a
37	JUND	chr5:79350562-79350828	HCT-116	colon:	n/a	n/a
38	JUND	chr5:79331107-79331308	H1-hESC	embryonic stem cell:	n/a	n/a
39	JUND	chr5:79330896-79331034	H1-hESC	embryonic stem cell:	n/a	n/a
40	JUND	chr5:79331314-79331448	H1-hESC	embryonic stem cell:	n/a	n/a
41	MAFF	chr5:79350646-79350805	HepG2	liver:	n/a	n/a
42	MAFF	chr5:79339025-79339392	HepG2	liver:	n/a	n/a
43	MAFF	chr5:79339080-79339357	K562	blood:	n/a	n/a
44	MAFK	chr5:79339105-79339305	H1-hESC	embryonic stem cell:	n/a	n/a
45	MAFK	chr5:79339024-79339397	HepG2	liver:	n/a	n/a
46	MAFK	chr5:79339052-79339276	Hela-S3	cervix:	n/a	n/a
47	MAFK	chr5:79339082-79339359	K562	blood:	n/a	n/a
48	MAFK	chr5:79353848-79354077	HepG2	liver:	n/a	chr5:79353992-79354003
49	MAFK	chr5:79350671-79350677	HepG2	liver:	n/a	n/a
50	MAFK	chr5:79339025-79339378	HepG2	liver:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:79330943-79330993	ovcar-3	ovarian:	n/a
2	chr5:79330669-79330719	HCPEpiC	choroid plexus:	n/a
3	chr5:79330959-79331009	BE2_C	brain:	n/a
4	chr5:79330959-79331009	HRE	kidney:	n/a
5	chr5:79331135-79331185	HPAEpiC	pulmonary alveolar:	n/a
6	chr5:79330959-79331009	HEEpiC	esophagus:	n/a
7	chr5:79330943-79330993	H1-hESC	embryonic stem cell:	embryo
8	chr5:79330943-79330993	SKMC	muscle:	n/a
9	chr5:79331047-79331097	PANC-1	pancreas:	n/a
10	chr5:79330799-79330849	BE2_C	brain:	n/a
11	chr5:79330799-79330849	PANC-1	pancreas:	n/a
12	chr5:79331850-79331900	AG04449	skin:	fetal
13	chr5:79330929-79330979	NHDF-neo	bronchial:	n/a
14	chr5:79330943-79330993	NH-A	brain:	n/a
15	chr5:79331047-79331097	SAEC	small airway:	n/a
16	chr5:79331135-79331185	HL-60	blood:	n/a
17	chr5:79331477-79331527	CMK	blood:	n/a
18	chr5:79331850-79331900	HRE	kidney:	n/a
19	chr5:79330929-79330979	MCF-7	breast:	n/a
20	chr5:79330959-79331009	HEK293	kidney:	embryo
21	chr5:79330959-79331009	Caco-2	colon:	n/a
22	chr5:79330669-79330719	CMK	blood:	n/a
23	chr5:79334767-79334817	RPTEC	kidney:	n/a
24	chr5:79330959-79331009	AG10803	skin:	n/a
25	chr5:79331477-79331527	MCF10A-Er-Src	breast:	n/a
26	chr5:79330929-79330979	AG09309	skin:	n/a
27	chr5:79331850-79331900	MCF-7	breast:	n/a
28	chr5:79331850-79331900	GM12892	blood:	n/a
29	chr5:79330669-79330719	IMR90	lung:	fetal
30	chr5:79330929-79330979	ECC-1	luminal epithelium:	n/a
31	chr5:79330959-79331009	GM12878	blood:	n/a
32	chr5:79330669-79330719	T-47D	breast:	n/a
33	chr5:79330799-79330849	SKMC	muscle:	n/a
34	chr5:79331477-79331527	HRE	kidney:	n/a
35	chr5:79330799-79330849	T-47D	breast:	n/a
36	chr5:79330929-79330979	HEK293	kidney:	embryo
37	chr5:79330959-79331009	SKMC	muscle:	n/a
38	chr5:79334767-79334817	A549	lung:	n/a
39	chr5:79331047-79331097	Caco-2	colon:	n/a
40	chr5:79331477-79331527	SAEC	small airway:	n/a
41	chr5:79331850-79331900	PFSK-1	brain:	n/a
42	chr5:79330959-79331009	HUVEC	blood vessel:	n/a
43	chr5:79330669-79330719	MCF10A-Er-Src	breast:	n/a
44	chr5:79331047-79331097	AG09309	skin:	n/a
45	chr5:79330929-79330979	HRCEpiC	kidney:	n/a
46	chr5:79330959-79331009	HRPEpiC	eye:	n/a
47	chr5:79331477-79331527	HCPEpiC	choroid plexus:	n/a
48	chr5:79330669-79330719	HUVEC	blood vessel:	n/a
49	chr5:79331850-79331900	ProgFib	skin:	n/a
50	chr5:79331850-79331900	AG09319	gingival:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:79342559..79344595-chr5:79353378..79355370,2	MCF-7	breast:
2	chr5:79332099..79334519-chr5:79339709..79341668,2	K562	blood:
3	chr5:79335840..79338759-chr5:79340815..79343092,2	K562	blood:
4	chr5:79333872..79336859-chr5:79337691..79339554,2	K562	blood:
5	chr5:79333872..79336859-chr5:79337691..79339554,2	K562	blood:
6	chr5:79342559..79344595-chr5:79353378..79355370,2	MCF-7	breast:
7	chr5:79335840..79338759-chr5:79340815..79343092,2	K562	blood:
8	chr5:79348642..79351231-chr5:79351742..79353321,2	MCF-7	breast:
9	chr5:79348642..79351231-chr5:79351742..79353321,2	MCF-7	breast:
10	chr5:79341846..79342632-chr5:79379301..79379935,2	K562	blood:
11	chr5:79332099..79334519-chr5:79339709..79341668,2	K562	blood:
12	chr5:79350174..79351742-chr5:79371407..79373227,2	MCF-7	breast:
13	chr5:79196588..79198348-chr5:79339313..79342153,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SERINC5-1	chr5:79348197-79348724	ENSG00000249825.1

No data

Variant related genes	Relation type
TRMT112P2	TF binding region
THBS4	TF binding region
TRMT112P2	CpG island
THBS4	CpG island
ENSG00000249825	chromatin interactions

Extended variants
information (count: 932 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:932 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3813667	chr5:79330559-79330560	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs184581143	chr5:79330590-79330591	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs147653575	chr5:79330597-79330598	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs149109223	chr5:79330601-79330602	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs545532382	chr5:79330625-79330626	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs188500699	chr5:79330632-79330633	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs575106958	chr5:79330649-79330650	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs544057553	chr5:79330681-79330682	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	CpG island	2 gene(s)	Overlapped CNVs	n/a
9	rs560873901	chr5:79330729-79330730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs529659656	chr5:79330749-79330750	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs556558520	chr5:79330773-79330774	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs546264750	chr5:79330777-79330778	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs201719643	chr5:79330783-79330784	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs181275768	chr5:79330799-79330800	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
15	rs560120285	chr5:79330801-79330802	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
16	rs143032034	chr5:79330819-79330820	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs186701255	chr5:79330833-79330834	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
18	rs114963482	chr5:79330845-79330846	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
19	rs189079096	chr5:79330859-79330860	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs551267378	chr5:79330944-79330945	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
21	rs567975180	chr5:79330945-79330946	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs536980982	chr5:79331071-79331072	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
23	rs553090896	chr5:79331147-79331148	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
24	rs4425490	chr5:79331194-79331195	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs538718070	chr5:79331229-79331230	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs558632577	chr5:79331260-79331261	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs17878424	chr5:79331264-79331265	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs544018935	chr5:79331291-79331292	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs554380164	chr5:79331328-79331329	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs3749684	chr5:79331438-79331439	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs540565168	chr5:79331495-79331496	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
32	rs148180881	chr5:79331537-79331538	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs17886956	chr5:79331538-79331539	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs190923205	chr5:79331642-79331643	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs562592070	chr5:79331650-79331651	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs541403998	chr5:79331673-79331674	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs531091682	chr5:79331712-79331713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs551179525	chr5:79331719-79331720	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs557693869	chr5:79331736-79331737	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs577633058	chr5:79331775-79331776	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs145312701	chr5:79331800-79331801	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs17882731	chr5:79331862-79331863	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs372206815	chr5:79331929-79331930	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs539046933	chr5:79331938-79331939	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs181373559	chr5:79331939-79331940	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs535853834	chr5:79332012-79332013	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs568996643	chr5:79332019-79332020	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs546975855	chr5:79332122-79332123	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs554337397	chr5:79332148-79332149	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs574612411	chr5:79332158-79332159	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelofibrosis	22110671	CNVD
craniofacial dysmorphism	21918468	CNVD
lymphocytic leukemia	21291569	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:336 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:79330000-79330600	Bivalent Enhancer	Fetal Kidney	kidney
2	chr5:79330200-79330600	Bivalent Enhancer	Fetal Muscle Leg	muscle
3	chr5:79330200-79332200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
4	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
5	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
6	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
7	chr5:79330400-79330600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
8	chr5:79330400-79330600	Bivalent/Poised TSS	Cortex derived primary cultured neurospheres	brain
9	chr5:79330400-79330800	Active TSS	Ovary	ovary
10	chr5:79330400-79331400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
11	chr5:79330400-79331600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
12	chr5:79330400-79331600	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr5:79330400-79332000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
14	chr5:79330400-79332200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
15	chr5:79330600-79330800	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr5:79330600-79330800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
18	chr5:79330600-79330800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
19	chr5:79330600-79330800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
20	chr5:79330600-79330800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
21	chr5:79330600-79330800	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
22	chr5:79330600-79330800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
23	chr5:79330600-79330800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr5:79330600-79330800	Bivalent Enhancer	Liver	Liver
25	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
26	chr5:79330600-79330800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
27	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
28	chr5:79330600-79330800	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
29	chr5:79330600-79330800	Bivalent Enhancer	Thymus	Thymus
30	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
31	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
33	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
35	chr5:79330600-79331000	Bivalent/Poised TSS	NHEK	skin
36	chr5:79330600-79331200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
37	chr5:79330600-79331200	Bivalent/Poised TSS	Psoas Muscle	Psoas
38	chr5:79330600-79331200	Bivalent/Poised TSS	Right Ventricle	heart
39	chr5:79330600-79331400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
40	chr5:79330600-79331400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr5:79330600-79331400	Bivalent/Poised TSS	Fetal Brain Female	brain
42	chr5:79330600-79331600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
43	chr5:79330600-79331600	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
44	chr5:79330600-79331600	Bivalent/Poised TSS	Primary T cells from cord blood	blood
45	chr5:79330600-79331600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
46	chr5:79330600-79331600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
47	chr5:79330600-79331600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
48	chr5:79330600-79331600	Active TSS	Brain Anterior Caudate	brain
49	chr5:79330600-79331600	Bivalent Enhancer	Fetal Intestine Small	intestine
50	chr5:79330600-79331600	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links